- Home
- WTTR vs EYPT Comparison
WTTR vs EYPT Comparison
Compare WTTR & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTTR
- EYPT
- Stock Information
- Founded
- WTTR 2016
- EYPT 1987
- Country
- WTTR United States
- EYPT United States
- Employees
- WTTR N/A
- EYPT N/A
- Industry
- WTTR Oilfield Services/Equipment
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- WTTR Energy
- EYPT Industrials
- Exchange
- WTTR Nasdaq
- EYPT Nasdaq
- Market Cap
- WTTR 922.1M
- EYPT 741.0M
- IPO Year
- WTTR 2017
- EYPT 2005
- Fundamental
- Price
- WTTR $8.41
- EYPT $14.01
- Analyst Decision
- WTTR Strong Buy
- EYPT Strong Buy
- Analyst Count
- WTTR 3
- EYPT 6
- Target Price
- WTTR $15.00
- EYPT $25.83
- AVG Volume (30 Days)
- WTTR 979.2K
- EYPT 708.2K
- Earning Date
- WTTR 11-04-2025
- EYPT 11-06-2025
- Dividend Yield
- WTTR 3.34%
- EYPT N/A
- EPS Growth
- WTTR N/A
- EYPT N/A
- EPS
- WTTR 0.32
- EYPT N/A
- Revenue
- WTTR $1,458,995,000.00
- EYPT $51,898,000.00
- Revenue This Year
- WTTR N/A
- EYPT N/A
- Revenue Next Year
- WTTR $0.71
- EYPT N/A
- P/E Ratio
- WTTR $26.03
- EYPT N/A
- Revenue Growth
- WTTR N/A
- EYPT 2.99
- 52 Week Low
- WTTR $7.20
- EYPT $3.91
- 52 Week High
- WTTR $15.14
- EYPT $14.37
- Technical
- Relative Strength Index (RSI)
- WTTR 47.09
- EYPT 77.25
- Support Level
- WTTR $8.29
- EYPT $11.38
- Resistance Level
- WTTR $8.73
- EYPT $12.24
- Average True Range (ATR)
- WTTR 0.27
- EYPT 0.74
- MACD
- WTTR 0.07
- EYPT 0.13
- Stochastic Oscillator
- WTTR 63.01
- EYPT 89.80
About WTTR Select Water Solutions Inc.
Select Water Solutions Inc provides sustainable water and chemical solutions to the energy industry. These solutions are supported by the company's critical water infrastructure assets, chemical manufacturing, and water treatment and recycling capabilities. Its reportable segments are Water Services, Water Infrastructure and Chemical Technologies. It generates the majority of its revenue from Water Services segment.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.